Dina M. Martin

Cytokine Gene Therapy of Cancer Using Interleukin‐12: Murine and Clinical Trials

L. Zitvogel, T. Whiteside, H. Tahara, 1996, Annals of the New York Academy of Sciences.

Third Keystone Symposium on Cellular Immunology and the Immunotherapy of Cancer Antigen Processing and Presentation Autologous Human Dendriphages Pulsed with Synthetic or Natural Tumor Peptides Elicit Tumor‐Specific CTLs In Vitro

M. Lotze, M. Maeurer, C. Castelli, 1998, Journal of immunotherapy.

Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes

M. Lotze, M. Maeurer, C. Castelli, 1995, Cancer Immunology, Immunotherapy.

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

J. Bryant, M. Lotze, S. Gollin, 1996, The Journal of clinical investigation.

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

M. Lotze, G. Parmiani, M. Maeurer, 1995, The Journal of experimental medicine.

Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin

L. Zitvogel, M. Lotze, M. Maeurer, 1996, The Journal of experimental medicine.

Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.

C. Wilson, C. Slingluff, M. Lotze, 1998, Journal of immunology.

Interleukin‐7 (IL‐7) in Colorectal Cancer: IL‐7 is Produced by Tissues from Colorectal Cancer and Promotes Preferential Expansion of Tumour Infiltrating Lymphocytes

L. Zitvogel, M. Lotze, W. Storkus, 1997, Scandinavian journal of immunology.